Yuka
Yuka aims for sensible translations that capture the nuances of the original, and will continue to introduce Chinese-language books that are both entertaining and meaningful.
She is a Ph.D. candidate at Yonsei University’s HCI Lab. She is currently working with HAII (a company specializing in digital therapeutics) on the planning, development, and clinical trials of a digital therapeutic for language therapy targeting stroke patients. She has directly experienced the A to Z of creating digital therapeutics and researches how patients can better and continuously benefit from digital therapy. She co-authored The Digital Therapeutics Revolution: Everything About the Third New Drug, Digital Therapeutics (2022).